Increased context-dependent conditioning to amphetamine in mice lacking TAAR1

Pharmacological Research

Volumn 103, Issue , 2016, Pages 206-214

  Sukhanov, Ilya ^a,b   Caffino, Lucia ^c   Efimova, Evgeniya V ^d,e   Espinoza, Stefano ^a   Sotnikova, Tatiana D ^a,c   Cervo, Luigi ^f   Fumagalli, Fabio ^c   Gainetdinov, Raul R ^a,d,e  

^a ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^b PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

^c UNIVERSITY OF MILAN   (Italy)

^d SKOLKOVO INSTITUTE OF SCIENCE AND TECHNOLOGY   (Russian Federation)

^e ST PETERSBURG STATE UNIVERSITY   (Russian Federation)

^f MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Amphetamine; Conditioning; NMDA glutamate receptors; Trace amine associated receptor 1 (TAAR1)

Indexed keywords

AMPHETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; RECEPTOR PROTEIN; TRACE AMINE ASSOCIATED RECEPTOR 1; UNCLASSIFIED DRUG; G PROTEIN COUPLED RECEPTOR; GPRIN1 PROTEIN, MOUSE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NERVE PROTEIN; TRACE AMINE-ASSOCIATED RECEPTOR 1;

ANIMAL EXPERIMENT; ARTICLE; CONDITIONING; CONTROLLED STUDY; DRUG DEPENDENCE; LOCOMOTION; MOLECULAR PATHOLOGY; MOUSE; NEUROTRANSMISSION; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SENSITIZATION; WILD TYPE; ANIMAL; ANIMAL BEHAVIOR; CORPUS STRIATUM; DRUG EFFECTS; FEMALE; GENETICS; INSTRUMENTAL CONDITIONING; KNOCKOUT MOUSE; MALE; METABOLISM;

AMPHETAMINE; ANIMALS; BEHAVIOR, ANIMAL; CONDITIONING, OPERANT; CORPUS STRIATUM; FEMALE; LOCOMOTION; MALE; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84949560105     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2015.11.002     Document Type: Article

References (59)

1. D.J. Heal, S.L. Smith, J. Gosden, and D.J. Nutt Amphetamine, past and present-a pharmacological and clinical perspective J. Psychopharmacol. 27 2013 479 496
2. S.R. Jones, R.R. Gainetdinov, R.M. Wightman, and M.G. Caron Mechanisms of Amphetamine action revealed in mice lacking the dopamine transporter J. Neurosci. 18 1998 1979 1986
3. E.A. Budygin, M.S. Brodie, T.D. Sotnikova, Y. Mateo, C.E. John, M. Cyr, R.R. Gainetdinov, and S.R. Jones Dissociation of rewarding and dopamine transporter-mediated properties of amphetamine Proc. Natl. Acad. Sci. U. S. A. 101 2004 7781 7786
4. T.A. Mathews, C.E. John, G.B. Lapa, E.A. Budygin, and S.R. Jones No role of the dopamine transporter in acute ethanol effects on striatal dopamine dynamics Synapse 60 2006 288 294
5. S. Berman, J. O'Neill, S. Fears, G. Bartzokis, and E.D. London Abuse of amphetamines and structural abnormalities in the brain Ann. N.Y. Acad. Sci. 1141 2008 195 220
6. S.R. Philips, B. Rozdilsky, and A.A. Boulton Evidence for the presence of m-tyramine, p-tyramine, tryptamine, and phenylethylamine in the rat brain and several areas of the human brain Biol. Psychiatry 13 1978 51 57
7. R.T. Premont, R.R. Gainetdinov, and M.G. Caron Following the trace of elusive amines Proc. Natl. Acad. Sci. U. S. A. 98 2001 9474 9475
8. M.D.M. Berry Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators J. Neurochem. 90 2004 257 271
9. T.A. Branchek, and T.P. Blackburn Trace amine receptors as targets for novel therapeutics: Legend, myth and fact Curr. Opin. Pharmacol. 3 2003 90 97
10. D.K. Grandy Trace amine-associated receptor 1-family archetype or iconoclast Pharmacol. Ther. 116 2007 355 390
11. L. Lindemann, and M.C. Hoener A renaissance in trace amines inspired by a novel gpcr family Trends Pharmacol. Sci. 26 2005 274 281
12. L.S. Barak, A. Salahpour, X. Zhang, B. Masri, T.D. Sotnikova, A.J. Ramsey, J.D. Violin, R.J. Lefkowitz, M.G. Caron, and R.R. Gainetdinov Pharmacological characterization of membrane-expressed human trace amine-associated receptor 1 (taar1) by a bioluminescence resonance energy transfer camp biosensor Mol. Pharmacol. 74 2008 585 594
13. L. Lindemann, C.A. Meyer, K. Jeanneau, A. Bradaia, L. Ozmen, H. Bluethmann, B. Bettler, J.G. Wettstein, E. Borroni, J.L. Moreau, and M.C. Hoener Trace amine-associated receptor 1 modulates dopaminergic activity J. Pharmacol. Exp. Ther. 324 2008 948 956
14. A.N. Mead, and D.N. Stephens Cnqx but not nbqx prevents expression of amphetamine-induced place preference conditioning: A role for the glycine site of the nmda receptor, but not ampa receptors J. Pharmacol. Exp. Ther. 290 1999 9 15
15. E.A. Reese, J.R. Bunzow, S. Arttamangkul, M.S. Sonders, and D.K. Grandy Trace amine-associated receptor 1 displays species-dependent stereoselectivity for isomers of methamphetamine, amphetamine, and para-hydroxyamphetamine J. Pharmacol. Exp. Ther. 321 2007 178 186
16. D.B. Wainscott, S.P. Little, T. Yin, Y. Tu, V.P. Rocco, J.X. He, and D.L. Nelson Pharmacologic characterization of the cloned human trace amine-associated receptor1 (taar1) and evidence for species differences with the rat taar1 J. Pharmacol. Exp. Ther. 320 2007 475 485
17. T.D. Wolinsky, C.J. Swanson, K.E. Smith, H. Zhong, B. Borowsky, P. Seeman, T. Branchek, and C.P. Gerald The trace amine 1 receptor knockout mouse: An animal model with relevance to schizophrenia Genes. Brain Behav. 6 2007 628 639
18. Z. Xie, and G.M. Miller Trace amine-associated receptor 1 is a modulator of the dopamine transporter J Pharmacol. Exp. Ther. 321 2007 128 136
19. Z. Xie, S.V. Westmoreland, M.E. Bahn, G.L. Chen, H. Yang, E.J. Vallender, W.D. Yao, B.K. Madras, and G.M. Miller Rhesus monkey trace amine-associated receptor 1 signaling: enhancement by monoamine transporters and attenuation by the d2 autoreceptor in vitro J. Pharmacol. Exp. Ther. 321 2007 116 127
20. G.M. Miller, C.D. Verrico, A. Jassen, M. Konar, H. Yang, H. Panas, M. Bahn, R. Johnson, and B.K. Madras Primate trace amine receptor 1 modulation by the dopamine transporter J. Pharmacol. Exp. Ther. 313 2005 983 994
21. S. Espinoza, G. Lignani, L. Caffino, S. Maggi, I. Sukhanov, D. Leo, L. Mus, M. Emanuele, G. Ronzitti, A. Harmeier, L. Medrihan, T.D. Sotnikova, E. Chieregatti, M.C. Hoener, F. Benfenati, V. Tucci, F. Fumagalli, and R.R. Gainetdinov Taar1 modulates cortical glutamate nmda receptor function Neuropsychopharmacology 2015
22. S. Espinoza, V. Ghisi, M. Emanuele, D. Leo, I. Sukhanov, T.D. Sotnikova, E. Chieregatti, and R.R. Gainetdinov Postsynaptic d2 dopamine receptor supersensitivity in the striatum of mice lacking taar1 Neuropharmacology 93 2015 308 313
23. B. Borowsky, N. Adham, K.A. Jones, R. Raddatz, R. Artymyshyn, K.L. Ogozalek, M.M. Durkin, P.P. Lakhlani, J.A. Bonini, S. Pathirana, N. Boyle, X. Pu, E. Kouranova, H. Lichtblau, F.Y. Ochoa, T.A. Branchek, and C. Gerald Trace amines: Identification of a family of mammalian g protein-coupled receptors Proc. Natl. Acad. Sci. U. S.A 98 2001 8966 8971
24. R. Cotter, Y. Pei, L. Mus, A. Harmeier, R.R. Gainetdinov, M.C. Hoener, and J.J. Canales The trace amine-associated receptor 1 modulates methamphetamine's neurochemical and behavioral effects Front. Neurosci. 9 39 2015
25. Y. Pei, J. Lee, D. Leo, R.R. Gainetdinov, M.C. Hoener, and J.J. Canales Activation of the trace amine-associated receptor 1 prevents relapse to cocaine seeking Neuropsychopharmacology 39 2014 2299 2308
26. Y. Pei, P. Mortas, M.C. Hoener, and J.J. Canales Selective activation of the trace amine-associated receptor 1 decreases cocaine's reinforcing efficacy and prevents cocaine-induced changes in brain reward thresholds Prog. Neuropsychopharmaco.l Biol. Psychiatry 63 2015 70 75
27. F.G. Revel, J.L. Moreau, R.R. Gainetdinov, A. Ferragud, C. Velazquez-Sanchez, T.D. Sotnikova, S.R. Morairty, A. Harmeier, Z. Groebke, K. binden, R.D. Norcross, A. Bradaia, T.S. Kilduff, B. Biemans, B. Pouzet, M.G. Caron, J.J. Canales, T.L. Wallace, J.G. Wettstein, and M.C. Hoener Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics Biol. Psychiatry 72 2012 934 942
28. L. Jing, Y. Zhang, and J.X. Li Effects of the trace amine associated receptor 1 agonist RO5263397 on abuse-related behavioral indices of methamphetamine in rats Int. J. Neuropsychopharmacol. 18 2014 1 7
29. D.A. Thorn, L. Jing, Y. Qiu, A.M. Gancarz-Kausch, C.M. Galuska, D.M. Dietz, Y. Zhang, and J.X. Li Effects of the trace amine-associated receptor 1 agonist RO5263397 on abuse-related effects of cocaine in rats Neuropsychopharmacology 39 2014 2309 2316
30. I. Sukhanov, S. Espinoza, D.S. Yakovlev, M.C. Hoener, T.D. Sotnikova, and R.R. Gainetdinov Taar1-dependent effects of apomorphine in mice Int. J. Neuropsychopharmacol. 17 2014 1683 1693
31. D. Leo, L. Mus, S. Espinoza, M.C. Hoener, T.D. Sotnikova, and R.R. Gainetdinov Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of d2 dopamine autoreceptors Neuropharmacology 81 2014 283 291
32. S. Espinoza, B. Masri, A. Salahpour, and R.R. Gainetdinov Bret approaches to characterize dopamine and taar1 receptor pharmacology and signaling Methods Mol. Biol. 964 2013 107 122
33. L. Jing, and J.X. Li Trace amine-associated receptor 1: a promising target for the treatment of psychostimulant addiction Eur. J. Pharmacol. 761 2015 345 352
34. J.J. Battisti, N.J. Uretsky, and L.J. Wallace Importance of environmental context in the development of amphetamine- or apomorphine-induced stereotyped behavior after single and multiple doses Pharmacol. Biochem. Behav. 66 2000 435 441
35. O.A. Dravolina, W. Danysz, and A.Y. Bespalov Effects of group i metabotropic glutamate receptor antagonists on the behavioral sensitization to motor effects of cocaine in rats Psychopharmacology (Berl.) 187 2006 397 404
36. J.D. Steketee, and P.W. Kalivas Drug wanting: behavioral sensitization and relapse to drug-seeking behavior Pharmacol. Rev. 63 2011 348 365
37. A. Laakso, A.R. Mohn, R.R. Gainetdinov, and M.G. Caron Experimental genetic approaches to addiction Neuron 36 2002 213 228
38. M. Morales, E.I. Varlinskaya, and L.P. Spear Evidence for conditioned place preference to a moderate dose of ethanol in adult male sprague-dawley rats Alcohol 46 2012 643 648
39. M.T. Bardo, J.M. Valone, and R.A. Bevins Locomotion and conditioned place preference produced by acute intravenous amphetamine: Role of dopamine receptors and individual differences in amphetamine self-administration Psychopharmacology (Berl.) 143 1999 39 46
40. G. Biala, C. Betancur, I.M. Mansuy, and B. Giros The reinforcing effects of chronic D-amphetamine and morphine are impaired in a line of memory-deficient mice overexpressing calcineurin Eur. J. Neurosci. 21 2005 3089 3096
41. A. Salahpour, A.J. Ramsey, I.O. Medvedev, B. Kile, T.D. Sotnikova, E. Holmstrand, V. Ghisi, P.J. Nicholls, L. Wong, K. Murphy, S.R. Sesack, R.M. Wightman, R.R. Gainetdinov, and M.G. Caron Increased amphetamine-induced hyperactivity and reward in mice overexpressing the dopamine transporter Proc. Natl. Acad. Sci. U. S. A. 105 2008 4405 4410
42. F. Fumagalli, M. Pasini, A. Frasca, F. Drago, G. Racagni, and M.A. Riva Prenatal stress alters glutamatergic system responsiveness in adult rat prefrontal cortex J. Neurochem. 109 2009 1733 1744
43. S. Moriguchi, S. Watanabe, H. Kita, and H. Nakanishi Enhancement of n-methyl- D-aspartate receptor-mediated excitatory postsynaptic potentials in the neostriatum after methamphetamine sensitization. An in vitro slice study Exp. Brain Res. 144 2002 238 246
44. C. Achat-Mendes, L.J. Lynch, K.A. Sullivan, E.J. Vallender, and G.M. Miller Augmentation of methamphetamine-induced behaviors in transgenic mice lacking the trace amine-associated receptor 1 Pharmacol. Biochem. Behav. 101 2012 201 207
45. P.K. Thanos, C. Bermeo, G.J. Wang, and N.D. Volkow D-cycloserine accelerates the extinction of cocaine-induced conditioned place preference in c57bl/c mice Behav. Brain Res. 199 2009 345 349
46. E.A. Budygin, M.S. Brodie, T.D. Sotnikova, Y. Mateo, C.E. John, M. Cyr, R.R. Gainetdinov, and S.R. Jones Dissociation of rewarding and dopamine transporter-mediated properties of amphetamine Proc. Natl. Acad. Sci. U.S.A. 101 2004 7781 7786
47. A. Wikler, Conditioning factors in opiate addiction and relapse. In: G. G., Willner DIK, ed. Narcotics. New York: McGraw-Hill, 1965.
48. A.Y. Bespalov, O.A. Dravolina, I. Sukhanov, E. Zakharova, E. Blokhina, E. Zvartau, W. Danysz, H. van, G. eeke, and A. Markou Metabotropic glutamate receptor (mglur5) antagonist mpep attenuated cue- and schedule-induced reinstatement of nicotine self-administration behavior in rats Neuropharmacology 49 Suppl 1 2005 167 178
49. O.A. Dravolina, E.S. Zakharova, E.V. Shekunova, E.E. Zvartau, W. Danysz, and A.Y. Bespalov Mglu1 receptor blockade attenuates cue- and nicotine-induced reinstatement of extinguished nicotine self-administration behavior in rats Neuropharmacology 52 2007 263 269
50. A.M. Young, P.M. Moran, and M.H. Joseph The role of dopamine in conditioning and latent inhibition: what, when, where and how? Neurosci. Biobehav. Rev. 29 2005 963 976
51. J.J. Day, and R.M. Carelli The nucleus accumbens and pavlovian reward learning Neuroscientist 13 2007 148 159
52. M.J. Acerbo, A.M. Godoy, and J.D. Delius Haloperidol blocks the acquisition but not the retrieval of a conditioned sensitization to apomorphine Behav. Pharmacol. 14 2003 631 640
53. L. Cervo, and R. Samanin Effects of dopaminergic and glutamatergic receptor antagonists on the establishment and expression of conditioned locomotion to cocaine in rats Brain Res. 731 1996 31 38
54. S.R. Weiss, R.M. Post, A. Pert, R. Woodward, and D. Murman Context-dependent cocaine sensitization: Differential effect of haloperidol on development versus expression Pharmacol. Biochem. Behav. 34 1989 655 661
55. L. Cervo, and R. Samanin Effects of dopaminergic and glutamatergic receptor antagonists on the acquisition and expression of cocaine conditioning place preference Brain Res. 673 1995 242 250
56. T.D. Sotnikova, E.A. Budygin, S.R. Jones, L.A. Dykstra, M.G. Caron, and R.R. Gainetdinov Dopamine transporter-dependent and -independent actions of trace amine beta-phenylethylamine J. Neurochem. 91 2004 362 373
57. S. Espinoza, A. Salahpour, B. Masri, T.D. Sotnikova, M. Messa, L.S. Barak, M.G. Caron, and R.R. Gainetdinov Functional interaction between trace amine-associated receptor 1 and dopamine d2 receptor Mol. Pharmacol. 80 2011 416 425
58. F.G. Revel, J.L. Moreau, R.R. Gainetdinov, A. Bradaia, T.D. Sotnikova, R. Mory, S. Durkin, K.G. Zbinden, R. Norcross, C.A. Meyer, V. Metzler, S. Chaboz, L. Ozmen, G. Trube, B. Pouzet, B. Bettler, M.G. Caron, J.G. Wettstein, and M.C. Hoener Taar1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity Proc. Natl. Acad. Sci. U. S. A. 108 2011 8485 8490
59. F.G. Revel, J.L. Moreau, B. Pouzet, R. Mory, A. Bradaia, D. Buchy, V. Metzler, S. Chaboz, Z. Groebke, K. binden, G. Galley, R.D. Norcross, D. Tuerck, A. Bruns, S.R. Morairty, T.S. Kilduff, T.L. Wallace, C. Risterucci, J.G. Wettstein, and M.C. Hoener A new perspective for schizophrenia: Taar1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight Mol. Psychiatry 18 2013 543 556